胰岛素泵在糖尿病患者围手术期的应用  

The application of continuous subcutaneous insulin infusion(CSII) in diabetic patients in paraoperation period

作　　者：李青菊[1] 田晨光[1] 李鹏诺[1] 张苏和[1] 李凤良[1] 

机构地区：[1]郑州大学第二附属医院内分泌科,郑州市450014

出　　处：《中原医刊》2005年第16期5-6,共2页Central Plains Medical Journal

摘　　要：目的观察胰岛素泵在糖尿病患者围手术期应用的益处。方法对我院102例需要进行手术治疗的2型糖尿病患者分别给予每日多次注射胰岛素(MSII)和胰岛素泵(CSII)两种治疗,比较两组患者治疗前后血糖、血糖达标时间、胰岛素用量及术后并发症的发生率。结果两种治疗方法皆能有效控制血糖,但CSII组血糖达标时间明显短于MSII组、胰岛素用量及术后并发症的发生率CSII组明显少于MSII组。结论对于围手术期的糖尿病患者胰岛素泵的应用明显优于常规的胰岛素给入方式。Objective To investigate the effect of the use of continuous subcutaneous insulin infusion（CSII） in diabetic patients in paraoperation period. Methods 102 patients with type 2 diabetes in paraoperation period were divided into two groups according to different treatments： the MSII and the CSII. The blood glucose, the dose of insulin and the incidence rate in two groups were compared. Resuits Both are effective in controlling blood glucose, while the time consuming by standardizing the control of blood glucose in CSII group is shorter than that of MSII group obviously, and the insulin dose needed in CSII group is less than that in MSII group and the incidence rate of operation complication in the former group is less than that in the latter. Conclusion The application of continuous subcutaneous insulin infusion（CSII） is obviously superior to the conventional subcutaneous injection of insulin for diabetes in paraoperation period.

关 键 词：2型糖尿痛 胰岛素泵 手术 2型糖尿病患者 者围手术期 术后并发症 控制血糖 围手术期应用 手术治疗 CSII 

分 类 号：R619[医药卫生—外科学]